• Profile
Close

Goa to start administering Remdesivir to COVID-19 patients

IANS Aug 08, 2020

The Goa's Health Ministry on August 7 received 1,008 vials of Remdesivir from pharma major Cipla. Remdesivir is an anti-viral drug that is administered to COVID-19 patients and results in faster recovery, the state Health Minister said.

For our comprehensive coverage and latest updates on COVID-19 click here.


"This anti-viral drug will be beneficial in suppressing the viral replication of SARS-CoV-2, the coronavirus that causes COVID-19. Uncontrollable viral replication is often responsible for tissue damage and deaths in patients infected with the virus," he said in a statement. The minister also said that the anti-viral drug will be administered to moderately and severely-ill patients suffering from COVID-19 and would help to suppress the viral replication of SARS-CoV-2. "The drug will help in faster recovery of COVID-19 patients. Introduction of Remdesivir in the COVID-19 treatment protocol will also help us reduce COVID-19 deaths associated with co-morbidity," he said. Goa is currently witnessing a sustained spike in the number of COVID-19 cases. The state has recorded 7,614 coronavirus cases in all, out of which 2,095 are active. 66 people have died after contracting the deadly infection.

This news story is picked from a reputed newswire and is minimally edited by M3 India staff. M3 India does not hold any view for or against it.

x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay